HLYK · HealthLynked Corp · Executive Compensation
$2.09
At close · Oct 16
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Without raising additional capital, there is substantial doubt about the Company's ability to continue as a going concern through August 14, 2027.”View the 10-Q filed Aug 14, 2026
Market Cap
$6.17M
Shares
2.95M
Volume · Oct 16
1730
Avg daily vol (3M)
1178
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| George O'Leary | Interim Chief Financial Officer | Appointed | 2026-07-16 |
| Chris G. Pulos | director | Appointed | 2025-12-12 |
| Jason Bishara | director | Appointed | 2025-12-12 |
| Duncan McGillivray | Chief Operating Officer | Appointed | 2025-12-12 |
| David Rosal | Chief Financial Officer | Resigned | 2025-01-15 |
| Jeremy Daniel | Chief Financial Officer | Appointed | 2025-01-15 |
| William Crupi | Chief Operating Officer | Appointed | 2024-06-26 |
| David Rosal | Chief Financial Officer | Appointed | 2024-03-14 |
| George O'Leary | Chief Financial Officer | Resigned | 2024-01-11 |
| Paul J. Hobaica | director | Appointed | 2023-03-15 |
| Robert Mino | independent director | Resigned | 2023-03-15 |
Leadership
- David Rosal CFO
- Jeremy Daniel CFO
- Duncan McGillivray COO
- William Crupi COO
- Chris G. Pulos Board Member
- Daniel Hall Board Member
- Heather Monahan Board Member
- Jason Bishara Board Member
- Paul J. Hobaica Board Member
- Paul J. Hobaica, M.D. Board Member